This is National Epilepsy Awareness Month, with a campaign designed to raise awareness about the neurological disorder that affects around 200,000 new patients each year. Once considered a fringe treatment for epilepsy, cannabis has now moved to the forefront of epileptic research and will be a focus of the Cannabis and Epilepsy Symposium on November 17 in Denver. Thanks to new discoveries surrounding cannabidiol (CBD), a non-psychoactive compound found in cannabis and hemp, those suffering…

READ MORE: https://www.cannabisculture.com/content/2018/11/14/cannabis-and-epilepsy-symposium-in-denver-during-epilepsy-awareness-month/